Diabetes (Type 1)

This study will test whether a new tablet can help to treat diabetic kidney disease. The study will last for 56 weeks, and participants will be allocated to receive either the new tablet or placebo. There will be 10 study visits.

Anticipated date enrolment will close: March 2019

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

A comparative study of the safety and effectiveness of a new drug (PRN1008) as a treatment for PV and PF when taken with a corticosteroid and compare this to the safety and effectiveness of corticosteroid alone.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Neurological Conditions (Other) - MND, Spinal Cord Injury, Stroke

An early feasibility study of the safety of the Stentrode™ device in participants with loss of motor function due to paralysis from spinal cord injury, motor neuron disease, stroke, muscular dystrophy or loss of limbs.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Cardiac Related Conditions

There are over one million heart operations performed each year. After surgery, many patients report problems with concentration, focus and memory and this can last for 3 months or longer.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Diabetes (Type 2)

We are seeking volunteers for the SURPASS-4 study which is a clinical trial investigating the safety and effectiveness of tirzepatide when taken once weekly compared to insulin taken once daily in people with type 2 diabetes and increased cardiovascular risk.

    Trial phase 

    check
    Non-Drug
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    Diabetes (Type 2)

    We are seeking people with a condition, Diabetic Kidney Disease (DKD), to participate in a study. The study is testing a new way of treating DKD with an drug called "propagermanium".

    Trial phase 

    check
    Non-Drug
    Phase 1
    Phase 2
    Phase 3
    Phase 4